PMID- 36702045
OWN - NLM
STAT- MEDLINE
DCOM- 20230321
LR  - 20230321
IS  - 1878-0334 (Electronic)
IS  - 1871-4021 (Linking)
VI  - 17
IP  - 2
DP  - 2023 Feb
TI  - Effect of dates on blood glucose and other metabolic variables: A narrative 
      review.
PG  - 102705
LID - S1871-4021(23)00001-2 [pii]
LID - 10.1016/j.dsx.2023.102705 [doi]
AB  - BACKGROUND: There is a common belief that individuals with type 2 diabetes 
      mellitus (T2DM) must avoid consumption of dates. This article aims to review and 
      discuss the available studies on dates on different variables, specifically blood 
      glucose. METHODS: A survey of studies related to the influence of consumption of 
      dates on blood glucose, glycosylated hemoglobin, lipid profile, and body weight 
      was conducted between January 2009 and Nov 2022, using various data bases 
      (PubMed, Medline, Google Scholar and Scopus). RESULTS: The glycemic index (GI) of 
      date varieties ranges from 42.8 to 74.6, and glycemic load (GL) 8.5-24. The 
      glycemic indices of various stages of dates are; Rutab (semi-ripe), 47.2; Tamer 
      (fully ripe, traditionally sun-dried), 45.3, and Tamer (commercial), 35.5. 
      Glucose tolerance-based studies and cross-sectional studies show no significant 
      changes in glycemic indices or association with glycemic worsening with intake of 
      dates. Few randomized controlled trials (RCT) also showed no change in glycemia 
      and weight in the intervention groups consuming dates. Some data (including one 
      RCT) show that the consumption of dates improve total cholesterol and LDL-C. 
      CONCLUSIONS: Available studies show that consumption of dates may not lead to 
      impairment of glycemia in patients with T2DM, however, studies have several 
      limitations like small sample size and short duration. More RCTs pertaining to 
      the GI of different date varieties in different amounts are needed.
CI  - Copyright (c) 2023 Research Trust of DiabetesIndia (DiabetesIndia) and National 
      Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. 
      All rights reserved.
FAU - Meenakshi, Sachdev
AU  - Meenakshi S
AD  - Tamil Nadu Government Multi Super Specialty Hospital, Chennai, India.
FAU - Misra, Anoop
AU  - Misra A
AD  - Diabetes Foundation (India), Safdarjung Development Area, New Delhi, 110016, 
      India; National Diabetes Obesity and Cholesterol Foundation (N-DOC), Safdarjung 
      Development Area, New Delhi, 110016, India; Fortis C-DOC Center of Excellence for 
      Diabetes, Metabolic Diseases, and Endocrinology, B-16, Chirag Enclave, New Delhi, 
      India. Electronic address: anoopmisra@gmail.com.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230109
PL  - Netherlands
TA  - Diabetes Metab Syndr
JT  - Diabetes & metabolic syndrome
JID - 101462250
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin)
SB  - IM
MH  - Humans
MH  - *Blood Glucose/metabolism
MH  - Glycemic Index
MH  - Glycated Hemoglobin
MH  - *Diabetes Mellitus, Type 2
OTO - NOTNLM
OT  - Body weight
OT  - Dates
OT  - Diabetes
OT  - Glycemic index
OT  - Glycemic load
OT  - Lipids
EDAT- 2023/01/27 06:00
MHDA- 2023/03/22 06:00
CRDT- 2023/01/26 18:17
PHST- 2022/11/30 00:00 [received]
PHST- 2022/12/30 00:00 [revised]
PHST- 2023/01/02 00:00 [accepted]
PHST- 2023/01/27 06:00 [pubmed]
PHST- 2023/03/22 06:00 [medline]
PHST- 2023/01/26 18:17 [entrez]
AID - S1871-4021(23)00001-2 [pii]
AID - 10.1016/j.dsx.2023.102705 [doi]
PST - ppublish
SO  - Diabetes Metab Syndr. 2023 Feb;17(2):102705. doi: 10.1016/j.dsx.2023.102705. Epub 
      2023 Jan 9.